Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 July 2025 | Story Tshepo Tsotetsi | Photo Kaleidoscope Studios
Global Student Well-being Summit 2025
Students from across South Africa and the continent gathered at the University of the Free State’s South Campus for the 2025 Global Student Well-Being Summit, engaging in three days of dialogue, learning, and collaboration.

The University of the Free State (UFS) recently hosted the 2025 Global Student Well-being Summit, bringing together more than 20 institutions from across South Africa and the African continent. The three-day event, which took place from 16 to 18 July at the UFS South Campus, was themed ‘Co-Creating Student Well-being Strategies from the Student’s Perspective’ and positioned students at the centre of the conversation on well-being in higher education.

Universities such as the University of Zambia, National University of Lesotho, University of Namibia, the international Limkokwing University of Creative Technology, and 15 South African universities were among those represented by students, academics, institutional leaders, and wellness experts. Together, they tackled pressing issues related to mental health, academic pressure, inclusion, identity, and care in university spaces.

 

Building a culture of well-being and collaboration

“We came here to address the critical issues that our students are facing, especially in relation to student well-being,” said Dr Temba Hlasho, Executive Director of Student Affairs at UFS, in his opening remarks. “In today’s fast-paced and demanding academic landscape, student well-being is essential for academic success, personal growth, and future career prospects.”

The summit’s programme included plenaries and parallel sessions covering a broad range of topics such as healthy masculinity, transactional sex, stigma and discrimination, and the struggles of minority groups in higher education. These sessions were led by a combination of students and staff, reflecting the summit’s commitment to co-creation.

In a recorded address, UFS Vice-Chancellor and Principal Prof Hester C. Klopper highlighted the need for a collective response to student well-being across institutions and national borders. “They are part of a shared human experience that demands a shared response,” she said. “Students are not merely receivers of academic knowledge – they are whole human beings… carrying hopes and fears, dreams and anxieties.”

Prof Klopper also pointed to the need for honesty and vulnerability in the sector. “We should not be scared to fail – as long as we fail forward,” she said, adding that innovation in student support comes not only from sharing best practices but from learning what doesn’t work.

Student participants described the summit as eye-opening and deeply personal. “I realised that mental health is crucial, serving as the driving force behind daily functioning,” said Olwethu Sigcu, a BCom in Economics and Finance (extended) student from the UFS Bloemfontein Campus. “I previously overlooked its significance, but the summit motivated me to adopt a more comprehensive approach to health – considering physical, mental, and spiritual well-being.”

Institutional Student Representative Council President Mpho Maloka said the experience offered both leadership growth and personal transformation. “As a young woman navigating complex spaces, I was given an opportunity to grow that I didn’t even know I needed,” she said. “This summit is not just another checkbox on a list of student initiatives – it represents a culture.”

Dr Hlasho also noted that the outcomes of the summit align with several United Nations Sustainable Development Goals, in particular SDG 3 (Good Health and Well-being), SDG 4 (Quality Education), and SDG 17 (Partnerships for the Goals). He encouraged students to lead the shift towards healthier, more inclusive communities, stressing the need for long-term impact driven by young people.

The summit closed with a clear message: student well-being is not a side programme but is foundational to academic success and meaningful social change. And it must be co-created with students, not for them.

 

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept